Found 51 matching trials
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE2 This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Show More Location
Banner University Medical Center - Tucson
Learn More & Join Trial
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma PHASE1 This phase I trial studies the side effects and best dose of BCMA CART cell...
Show More Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
Learn More & Join Trial
CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma PHASE1 A prospective study to evaluate the safety and efficacy of CART19 for refra...
Show More Location
the First Affiliated Hospital,School of Medicine, Zhejiang University
Learn More & Join Trial
CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) PHASE1 This is a single center, open-label phase 1/2 study to evaluate the safety ...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
CD19 Redirected Autologous T Cells for Hodgkin Lymphoma EARLY_PHASE1 Pilot open-label study to estimate the feasibility, safety and efficacy of ...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
Allogeneic CART-19 for Elderly Relapsed/Refractory CD19+ ALL PHASE1 The purpose of this study is to evaluate the safety and efficiency of allog...
Show More Location
Affiliated Hospital of Academy of Military Medical Sciences ,
Learn More & Join Trial
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus PHASE1 This is a single-center, single-arm, open-label phase 1/2 study of CART19 i...
Show More Location
Children's Hospital of Philadelphia
Learn More & Join Trial
Autologous CARTmeso/19 Against Pancreatic Cancer EARLY_PHASE1 Pancreatic cancer patients receive chimeric antigen receptor (CAR) T cells ...
Show More Location
First Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma PHASE1 The goal of this prospective, multicentric, single-arm, phase I/II clinical...
Show More Location
Hospital de Clínicas da UNICAMP
Learn More & Join Trial
Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia PHASE2 This is a single center, single arm, open-label phase II study to determine...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial